First, there are many areas of exciting opportunity. We're back to that challenge of picking winners. I think the whole point of having a broad-ranging investment in fundamental science and scholarship is to let the winners emerge, not only through the process of peer review but in the broader marketplace of ideas, inventions and discoveries that determines the flow of science.
I am very optimistic that, if we make broad-ranging support and the granting council is a priority, those areas will find themselves. We've picked a few areas already. They're obvious: artificial intelligence, quantum and so on. We made a big bet on building pandemic and infectious disease capacity. I think this will unfold well in the years ahead if we make a sustained, broad investment.